- Home
- BDX
as 10-04-2024 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 70.1B | IPO Year: | 1962 |
| Target Price: | $282.63 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.84 | EPS Growth: | -12.37 |
| 52 Week Low/High: | $218.75 - $269.52 | Next Earning Date: | 11-07-2024 |
| Revenue: | $19,828,000,000 | Revenue Growth: | 4.11% |
| Revenue Growth (this year): | 5.02% | Revenue Growth (next year): | 6.69% |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
TipRanks
2 days ago
Becton Dickinson in pact to to resolve vast majority of hernia litigation
Zacks
2 days ago
Three Reasons Why You Should Hold BDX Stock in Your Portfolio Now
MT Newswires
3 days ago
Becton, Dickinson and Company Reaches Settlement to Resolve 'Vast Majority' of Hernia Litigation
PR Newswire
3 days ago
BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
TipRanks
3 days ago
Becton Dickinson target raised, added to ‘Tactical Outperform’ list at Evercore
MT Newswires
4 days ago
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $290 From $286
MT Newswires
4 days ago
Citigroup Upgrades Becton Dickinson and Co. to Buy From Neutral, Adjusts Price Target to $275 From $255
Zacks
9 days ago
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.